Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

CAPS Rating: 1 out of 5

An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.

Results 1 - 20 of 34 : 1 2 Next »

Recs

0
Member Avatar pchop12316 (86.54) Submitted: 8/18/2014 11:44:57 AM : Underperform Start Price: $3.62 ALXA Score: +3.21

volatile & more than likely to drop in price substantially

Recs

0
Member Avatar pchop123 (79.61) Submitted: 7/31/2014 6:06:43 PM : Underperform Start Price: $4.86 ALXA Score: +30.76

likely todrop big again now

Recs

3
Member Avatar zzlangerhans (99.76) Submitted: 7/19/2014 1:22:32 AM : Underperform Start Price: $5.06 ALXA Score: +31.34

On August 7, we'll get the first concrete information on the launch of Adasuve. Alexza's partner Teva started marketing the drug in the US in March, so the Q2 earnings call should contain a full quarter of revenue. As I've stated previously, I don't expect Adasuve to catch on because its use is based on the principle that a psychotic and uncooperative mental patient will voluntarily inhale a sedative. This may happen in a minority of cases, but experienced providers are not likely to switch from the cheap IM medications that they are used to administering via "tackle and inject" in order to experiment with something expensive and counterintuitive.

Of course, I could be wrong about Adasuve. I've been wrong about drug launches several times before, although it's usually because I think a drug will be successful and yet it fails. On the other hand, I'm an active ER physician and I have not heard a peep about Adasuve outside of my stock research. I can confidently say that if I did not track biotech stocks, I would be unaware of Adasuve's existence. There have been no e-mails from any pharmacists or psychiatrists that we have an exciting new weapon at our disposal. I have not seen a mention of Adasuve in any of the trade publications that clutter my mailbox. I tried Googling "Adasuve emergency" and "Adasuve psychiatry" to see if I could find any favorable mention of the drug in the throwaways or in more respected sources and found nothing.

In short, I think the revenue numbers will be disappointing and Alexza's share price will take a strong hit after they are reported. Since Alexza is short on cash, taking on debt, and weak in pipeline I believe the failure of Adasuve will pose an existential threat to Alexza in the short term.

Recs

0
Member Avatar DiArcy (< 20) Submitted: 12/4/2013 8:19:43 PM : Outperform Start Price: $5.06 ALXA Score: -41.07

While Adasuve does not have a large market, the delivery device will change the standard of care in the United States. First patients will prefer it (fear of needles) and two doctors/hospitals will love it for preventing injury to their staffs and their patients (fear of being sued). The agreement with Teva will help finance them until more marketable drugs make it to market. Until then, Alexa looks forward to launching of Adasuve the United States and earning from Europe.

Recs

1
Member Avatar beauzaq (< 20) Submitted: 7/5/2011 2:00:10 PM : Outperform Start Price: $18.65 ALXA Score: -130.12

Everything I read says this stock was going to double when I bought it at 1.45 a month or so ago. I still feel very good about and I think it is still undervalued.

Recs

1
Member Avatar technlogic (< 20) Submitted: 7/2/2011 1:08:54 AM : Outperform Start Price: $18.70 ALXA Score: -130.19

Ascending Triangle

Recs

0
Member Avatar abltech (< 20) Submitted: 6/22/2011 2:53:26 PM : Outperform Start Price: $15.90 ALXA Score: -132.20

Great pipeline, well funded.

Recs

0
Member Avatar nizzer (< 20) Submitted: 6/22/2011 9:36:50 AM : Outperform Start Price: $15.80 ALXA Score: -131.66

Upcoming catalysts that will provide a high run up before pdufa. Between the upcoming rally, the potential of az-004, and their drug delivery technology this can be a multi-bagger by the end of the year and in the long term/

Recs

0
Member Avatar garypalys (< 20) Submitted: 6/7/2011 6:01:19 AM : Outperform Start Price: $16.90 ALXA Score: -132.87

Alexza is a strong company with a great pipeline!

Recs

0
Member Avatar guzclues1996 (37.98) Submitted: 4/22/2011 11:13:37 PM : Outperform Start Price: $15.50 ALXA Score: -126.40

ALXA is a stock that returns the favor in the risk you put in to it. I wouldnt be surprised if it hits 4.50 a share.

Recs

0
Member Avatar KarinPatrick (< 20) Submitted: 12/8/2010 9:19:17 PM : Outperform Start Price: $12.00 ALXA Score: -131.43

Stock gets a second chance to make their points in person to FDA. Low price right now. Much needed drug, takes agitation off of schizophrenia and Bipolor patients.

Recs

0
Member Avatar thalio (< 20) Submitted: 11/8/2010 2:47:15 PM : Outperform Start Price: $10.00 ALXA Score: -127.56

The company can address the safety issues from the recent CRL, and investors will greet the upcoming announcement of an FDA meeting date with optimism. Concerns of dilution down the road will be put aside in a run up off recent lows.

Recs

0
Member Avatar rauorski (42.62) Submitted: 10/31/2010 5:05:04 AM : Outperform Start Price: $10.50 ALXA Score: -133.83

Good drug.. will get approval!!!

Recs

0
Member Avatar ebitdat (< 20) Submitted: 9/23/2010 10:45:28 AM : Outperform Start Price: $35.20 ALXA Score: -166.16

Betting on approval

Recs

0
Member Avatar roalercoaster (23.22) Submitted: 5/2/2010 2:43:08 PM : Outperform Start Price: $31.10 ALXA Score: -155.13

I am looking for at least a doulbe from here into october.

Recs

0
Member Avatar lola99999 (< 20) Submitted: 12/16/2009 9:34:30 PM : Outperform Start Price: $22.70 ALXA Score: -164.59

ALXA

Recs

0
Member Avatar CaptainFiveBaggr (95.03) Submitted: 10/13/2009 1:41:42 PM : Outperform Start Price: $33.90 ALXA Score: -214.68

Time to double down on Alexza

Recs

2
Member Avatar tixlong (55.34) Submitted: 1/30/2009 2:20:52 PM : Outperform Start Price: $30.20 ALXA Score: -232.19

numerous smart fools...

Recs

3
Member Avatar scottedont (47.66) Submitted: 11/5/2008 9:26:27 PM : Underperform Start Price: $20.00 ALXA Score: +198.92

This is a sinking ship. This stock has been shot by freakin' sharks that have freakin' laser beams attached to their freakin' heads.

Recs

0
Member Avatar gatorc (38.29) Submitted: 5/17/2008 5:36:15 PM : Outperform Start Price: $56.10 ALXA Score: -138.56

need my meds

Results 1 - 20 of 34 : 1 2 Next »

Featured Broker Partners


Advertisement